Literature DB >> 12187954

Effect of hyperosmolar mannitol on convection-enhanced delivery into the rat brain stem.

David I Sandberg1, Mark A Edgar, Mark M Souweidane.   

Abstract

INTRODUCTION: Convection-enhanced delivery (CED) can safely achieve high local infusate concentrations within the rat brain stem with predictable distribution volumes. The authors investigated the effects of co-infusion or systemic administration of hyperosmolar mannitol on distribution parameters for infusions into the rat brain stem.
METHODS: Fifteen rats underwent stereotactic cannula placement into the pontine nucleus oralis (PnO) followed by infusions at a constant rate to a total volume of 1 microl. Five rats underwent infusion of fluorescein isothiocyanate (FITC)-dextran diluted in 20% mannitol. Five rats received an intraperitoneal injection of 20% mannitol 10 min prior to infusion of FITC-dextran diluted in isotonic saline. As a control group, 5 rats underwent infusion of FITC-dextran diluted in isotonic saline without mannitol administration. Serial brain sections were imaged using confocal microscopy with ultraviolet illumination, and distribution volume (Vd) was calculated by computer image analysis. Histologic analysis was performed on adjacent sections.
RESULTS: Volumes of distribution were not significantly increased by co-infusion of mannitol directly into the brain stem or by systemic mannitol administration compared to infusion without mannitol. Similarly, mannitol administration by either means failed to significantly alter maximal cross-sectional area or cranio-caudal extent of fluorescence. No animal demonstrated a postoperative neurological deficit or histologic evidence of tissue disruption.
CONCLUSIONS: Neither systemic administration nor co-infusion of hyperosmolar mannitol significantly affects distribution parameters for CED infusions into the rat brain stem.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187954     DOI: 10.1023/a:1016213315548

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

Review 1.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

Authors:  D R Groothuis
Journal:  Neuro Oncol       Date:  2000-01       Impact factor: 12.300

2.  Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.

Authors:  A Ghodsi; C Stein; T Derksen; I Martins; R D Anderson; B L Davidson
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

3.  Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

Authors:  R A Kroll; M A Pagel; L L Muldoon; S Roman-Goldstein; E A Neuwelt
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

4.  Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.

Authors:  A W Walter; A Gajjar; J S Ochs; J W Langston; R A Sanford; L E Kun; R Heideman
Journal:  Med Pediatr Oncol       Date:  1998-01

5.  High-flow microinfusion: tissue penetration and pharmacodynamics.

Authors:  P F Morrison; D W Laske; H Bobo; E H Oldfield; R L Dedrick
Journal:  Am J Physiol       Date:  1994-01

6.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Intracerebral clysis in a rat glioma model.

Authors:  J N Bruce; A Falavigna; J P Johnson; J S Hall; B D Birch; J T Yoon; E X Wu; R L Fine; A T Parsa
Journal:  Neurosurgery       Date:  2000-03       Impact factor: 4.654

8.  High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.

Authors:  I J Dunkel; J H Garvin; S Goldman; L J Ettinger; A M Kaplan; M Cairo; H Li; J M Boyett; J L Finlay
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

9.  Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group.

Authors:  R D Jenkin; C Boesel; I Ertel; A Evans; R Hittle; J Ortega; R Sposto; W Wara; C Wilson; J Anderson
Journal:  J Neurosurg       Date:  1987-02       Impact factor: 5.115

10.  Chemotherapy of pediatric brain-stem tumors.

Authors:  D S Fulton; V A Levin; W M Wara; M S Edwards; C B Wilson
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

View more
  8 in total

1.  Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.

Authors:  Neal Luther; Nai-Kong Cheung; Eleni P Souliopoulos; Ioannis Karampelas; Ioannis Karempelas; Daniel Bassiri; Mark A Edgar; Hong-Fen Guo; Ira Pastan; Philip H Gutin; Mark M Souweidane
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

2.  Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

Authors:  Keith B Neeves; Andrew J Sawyer; Conor P Foley; W Mark Saltzman; William L Olbricht
Journal:  Brain Res       Date:  2007-08-29       Impact factor: 3.252

3.  Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.

Authors:  E Aguilar Salegio; A P Kells; R M Richardson; P Hadaczek; J Forsayeth; J Bringas; S P Sardi; M A Passini; L S Shihabuddin; S H Cheng; M S Fiandaca; K S Bankiewicz
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

4.  Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study.

Authors:  U W Thomale; B Tyler; V M Renard; B Dorfman; M Guarnieri; H E Haberl; G I Jallo
Journal:  Childs Nerv Syst       Date:  2008-08-09       Impact factor: 1.475

5.  Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine.

Authors:  Mark M Souweidane; Giuseppe Occhiogrosso; Erika B Mark; Mark A Edgar; Ira J Dunkel
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

6.  Brain Stem Tumors.

Authors:  Ira J Dunkel; Mark M Souweidane
Journal:  Curr Treat Options Neurol       Date:  2005-07       Impact factor: 3.972

7.  Enhancement of electric field-mediated gene delivery through pretreatment of tumors with a hyperosmotic mannitol solution.

Authors:  J Henshaw; B Mossop; F Yuan
Journal:  Cancer Gene Ther       Date:  2010-09-17       Impact factor: 5.987

8.  Interstitial infusion of IL13-PE38QQR in the rat brain stem.

Authors:  Mark M Souweidane; Giuseppe Occhiogrosso; Erika B Mark; Mark A Edgar
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.